ANAB
AnaptysBio Inc
54.90$
-0.5%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 54.4% | 98.5% | 92.4% | 294.4% | 1,123.9% | 1,241.7% | 106.7% | 155.9% | 863.2% | 771.0% | 179.5% | 1.0% | |
| 45.6% | 1.5% | 7.6% | -194.4% | -1,023.9% | -1,141.7% | -6.7% | -55.9% | -763.2% | -671.0% | -79.5% | 99.0% | |
| 54.4% | 98.5% | 135.6% | 309.4% | 1,125.9% | 1,241.7% | 106.7% | 155.9% | 863.2% | 813.8% | 179.5% | 58.0% | |
| 14.9% | 20.4% | 25.7% | 93.4% | 310.5% | 201.2% | 25.1% | 34.0% | 356.2% | 244.5% | 46.4% | 21.6% | |
| 14.9% | 20.4% | 25.7% | 93.4% | 310.5% | 201.2% | 25.1% | 34.0% | 356.2% | 287.3% | 46.4% | 78.6% | |
| 30.7% | -18.9% | -18.1% | -287.8% | -1,334.4% | -1,342.9% | -31.8% | -89.9% | -1,119.4% | -958.3% | -125.9% | 20.4% | |
| 8.1% | 2.6% | 2.7% | 17.8% | 33.0% | 13.0% | 5.3% | 2.3% | 205.2% | 105.4% | 54.9% | 34.1% | |
| 22.3% | -30.0% | -25.5% | -300.7% | -1,237.0% | -1,218.6% | -26.6% | -91.5% | -1,251.1% | -953.7% | -159.1% | -5.6% | |
| 8.1% | 0.8% | 1.2% | 18.2% | -3.8% | -1.9% | 0.0% | -1.0% | 0.2% | 0.0% | 0.0% | 0.1% | |
| 1.5% | -30.8% | -25.5% | -300.7% | -1,233.1% | -1,216.7% | -26.6% | -91.5% | -1,251.3% | -953.7% | -159.1% | -5.6% | |
| 32.3% | -25.8% | -21.4% | -281.1% | -1,197.6% | -1,199.2% | -25.8% | -88.2% | -1,023.2% | -911.7% | -101.6% | 29.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.